STERIS PLC (STE) Stock Price, Forecast & Analysis
USA - NYSE:STE - IE00BFY8C754 - Common Stock
STE Key Statistics, Chart & Performance
The current stock price of STE is 263.29 USD. In the past month the price increased by 9.36%. In the past year, price increased by 22.84%.
STE Latest News, Press Relases and Analysis
STE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.67 | 222.97B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.23 | 201.33B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.84 | 143.55B | ||
| SYK | STRYKER CORP | 27.96 | 140.79B | ||
| IDXX | IDEXX LABORATORIES INC | 57.57 | 58.07B | ||
| BDX | BECTON DICKINSON AND CO | 13.36 | 55.24B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.98B | ||
| RMD | RESMED INC | 25.33 | 36.59B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.66 | 34.90B | ||
| DXCM | DEXCOM INC | 32.38 | 23.62B | ||
| PODD | INSULET CORP | 72.47 | 23.31B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.39 | 18.26B |
Related stock screener links
About STE
Company Profile
STERIS Plc engages in the provision of healthcare and life science products and service solutions. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
Company Info
STERIS PLC
70 Sir John Rogerson's Quay
DUBLIN D02 R296 IE
CEO: Walter M Rosebrough
Employees: 17787
Phone: 35312322000
STERIS PLC / STE FAQ
Can you describe the business of STERIS PLC?
STERIS Plc engages in the provision of healthcare and life science products and service solutions. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
Can you provide the latest stock price for STERIS PLC?
The current stock price of STE is 263.29 USD. The price increased by 2.46% in the last trading session.
Does STERIS PLC pay dividends?
STERIS PLC (STE) has a dividend yield of 0.97%. The yearly dividend amount is currently 2.23.
What is the ChartMill rating of STERIS PLC stock?
STE has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Which stock exchange lists STE stock?
STE stock is listed on the New York Stock Exchange exchange.
Would investing in STERIS PLC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on STE.
Can you provide the ownership details for STE stock?
You can find the ownership structure of STERIS PLC (STE) on the Ownership tab.
STE Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to STE. When comparing the yearly performance of all stocks, STE is one of the better performing stocks in the market, outperforming 83.03% of all stocks.
STE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to STE. Both the health and profitability get an excellent rating, making STE a very profitable company, without any liquidiy or solvency issues.
STE Financial Highlights
Over the last trailing twelve months STE reported a non-GAAP Earnings per Share(EPS) of 9.87. The EPS increased by 8.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.07% | ||
| ROA | 6.61% | ||
| ROE | 9.82% | ||
| Debt/Equity | 0.27 |
STE Forecast & Estimates
13 analysts have analysed STE and the average price target is 277.87 USD. This implies a price increase of 5.54% is expected in the next year compared to the current price of 263.29.
For the next year, analysts expect an EPS growth of 9.15% and a revenue growth 8.36% for STE